Literature DB >> 22955568

Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J mice.

William C Griffin1, Robin W McGovern, Guinevere H Bell, Patrick K Randall, Lawrence D Middaugh, Kennerly S Patrick.   

Abstract

INTRODUCTION: Prior research indicates methylphenidate (MPH) and alcohol (ethanol, EtOH) interact to significantly affect responses humans and mice. The present studies tested the hypothesis that MPH and EtOH interact to potentiate ethanol-related behaviors in mice.
METHODS: We used several behavioral tasks including: drug discrimination in MPH-trained and EtOH-trained mice, conditioned place preference (CPP), rota-rod and the parallel rod apparatus. We also used gas chromatographic methods to measure brain tissue levels of EtOH and the D- and L-isomers of MPH and the metabolite, ethylphenidate (EPH).
RESULTS: In discrimination, EtOH (1 g/kg) produced a significant leftward shift in the MPH generalization curve (1-2 mg/kg) for MPH-trained mice, but no effects of MPH (0.625-1.25 mg/kg) on EtOH discrimination in EtOH-trained mice (0-2.5 g/kg) were observed. In CPP, the MPH (1.25 mg/kg) and EtOH (1.75 g/kg) combination significantly increased time on the drug paired side compared to vehicle (30.7 %), but this was similar to MPH (28.8 %) and EtOH (33.6 %). Footslip errors measured in a parallel rod apparatus indicated that the drug combination was very ataxic, with footslips increasing 29.5 % compared to EtOH. Finally, brain EtOH concentrations were not altered by 1.75 g/kg EtOH combined with 1.25 mg/kg MPH. However, EtOH significantly increased D-MPH and L-EPH without changing L-MPH brain concentrations.
CONCLUSIONS: The enhanced behavioral effects when EtOH is combined with MPH are likely due to the selective increase in brain D-MPH concentrations. These studies are consistent with observations in humans of increased interoceptive awareness of the drug combination and provide new clinical perspectives regarding enhanced ataxic effects of this drug combination.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955568      PMCID: PMC3547134          DOI: 10.1007/s00213-012-2849-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

1.  Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol.

Authors:  J S Markowitz; C L DeVane; D W Boulton; Z Nahas; S C Risch; F Diamond; K S Patrick
Journal:  Drug Metab Dispos       Date:  2000-06       Impact factor: 3.922

2.  Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral delivery.

Authors:  Guinevere H Bell; William C Griffin; Kennerly S Patrick
Journal:  Pharmacol Biochem Behav       Date:  2011-09-08       Impact factor: 3.533

3.  Unconditioned and conditioned factors contribute to the 'reinstatement' of cocaine place conditioning following extinction in C57BL/6 mice.

Authors:  Karen K Szumlinski; Kimber L Price; Kelly A Frys; Lawrence D Middaugh
Journal:  Behav Brain Res       Date:  2002-10-17       Impact factor: 3.332

4.  Methylphenidate self-administration and conditioned place preference in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.

Authors:  Ike C dela Peńa; Hyung Seok Ahn; Ji Young Choi; Chan Young Shin; Jong Hoon Ryu; Jae Hoon Cheong
Journal:  Behav Pharmacol       Date:  2011-02       Impact factor: 2.293

5.  The discriminative stimulus properties of methylphenidate in C57BL/6J mice.

Authors:  Robin W McGovern; Lawrence D Middaugh; Kennerly S Patrick; William C Griffin
Journal:  Behav Pharmacol       Date:  2011-02       Impact factor: 2.293

6.  Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.

Authors:  Kennerly S Patrick; Robin L Williard; Adam L VanWert; Justin J Dowd; John E Oatis; Lawrence D Middaugh
Journal:  J Med Chem       Date:  2005-04-21       Impact factor: 7.446

7.  Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine.

Authors:  R Kuczenski; D S Segal
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

8.  Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment.

Authors:  Ike dela Peña; Jong Chan Lee; Han Lim Lee; Tae Seon Woo; Hae Chang Lee; Aee Ree Sohn; Jae Hoon Cheong
Journal:  Neurosci Lett       Date:  2012-03-05       Impact factor: 3.046

9.  Methylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuse.

Authors:  Jinmin Zhu; Thomas J Spencer; Lee-Yuan Liu-Chen; Joseph Biederman; Pradeep G Bhide
Journal:  Neuropharmacology       Date:  2011-04-23       Impact factor: 5.250

Review 10.  Timing of alcohol and other drug use.

Authors:  Christopher S Martin
Journal:  Alcohol Res Health       Date:  2008
View more
  11 in total

1.  A novel translational assay of response inhibition and impulsivity: effects of prefrontal cortex lesions, drugs used in ADHD, and serotonin 2C receptor antagonism.

Authors:  Trevor Humby; Jessica B Eddy; Mark A Good; Amy C Reichelt; Lawrence S Wilkinson
Journal:  Neuropsychopharmacology       Date:  2013-05-09       Impact factor: 7.853

Review 2.  Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.

Authors:  Lucy Her; Hao-Jie Zhu
Journal:  Drug Metab Dispos       Date:  2019-12-23       Impact factor: 3.922

3.  Sensitization and Tolerance Following Repeated Exposure to Caffeine and Alcohol in Mice.

Authors:  Christina E May; Harold L Haun; William C Griffin
Journal:  Alcohol Clin Exp Res       Date:  2015-07-02       Impact factor: 3.455

4.  Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus Methylphenidate.

Authors:  Kennerly S Patrick; Arthur B Straughn; Owen T Reeves; Hilary Bernstein; Robert Malcolm
Journal:  J Clin Psychopharmacol       Date:  2015-08       Impact factor: 3.153

Review 5.  Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance.

Authors:  James H Ho; George P Bailey; John R H Archer; Paul I Dargan; David M Wood
Journal:  Eur J Clin Pharmacol       Date:  2015-07-22       Impact factor: 2.953

6.  Influence of sensitization on the discriminative stimulus effects of methylphenidate in mice.

Authors:  Robin McGovern; Lauryn Luderman; Kelly Knecht; William C Griffin
Journal:  Behav Pharmacol       Date:  2014-12       Impact factor: 2.293

7.  Conditioned reinforcement and locomotor activating effects of caffeine and ethanol combinations in mice.

Authors:  Megan L T Hilbert; Christina E May; William C Griffin
Journal:  Pharmacol Biochem Behav       Date:  2013-07-18       Impact factor: 3.533

Review 8.  Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.

Authors:  Kennerly S Patrick; Timothy R Corbin; Cristina E Murphy
Journal:  J Pharm Sci       Date:  2014-10-09       Impact factor: 3.534

9.  Effect of caffeine on alcohol drinking in mice.

Authors:  Harold L Haun; Anne C K Olsen; Katharina E Koch; Lauryn N Luderman; Christina E May; William C Griffin
Journal:  Alcohol       Date:  2021-03-26       Impact factor: 2.558

10.  Inhibition of urokinase plasminogen activator "uPA" activity alters ethanol consumption and conditioned place preference in mice.

Authors:  Elyazia Al Maamari; Mouza Al Ameri; Shamma Al Mansouri; Amine Bahi
Journal:  Drug Des Devel Ther       Date:  2014-09-16       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.